Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • carcorpgm carcorpgm Feb 18, 2014 10:33 AM Flag

    This is what Piper had to say

    •Piper's Josh Schimmer says that a key opinion leader will soon publish data that will get Insmed's (INSM +6.2%) Arikace lung-infection treatment approved based on a primary end-point.
    •Piper is as confident of Arikace's speedy approval as it was with the prospect of Vanda receiving FDA authorization for its Hetlioz sleep-wake disorder drug - the therapy was approved at the end of January

 
INSM
25.13+0.92(+3.80%)Aug 27 4:00 PMEDT